Home
About
Services
Partners
Client Portfolio
News
Contact
Turkey doubles tariffs on some U.S. imports; Turkish lira rallies
August 15, 2018
Chinese oil importers shun U.S. crude despite tariff reversal
August 15, 2018
0
Long-acting injection a shot in the arm for GSK’s HIV business
Published by
Muller&Green
at
August 15, 2018
Categories
RSS
Tags
A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker’s key HIV business.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more